Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 13Glioblastoma 12Sarcoma 3Astrocytoma 3Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Fibrosarcoma 2Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Pinealoma 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroma, Acoustic 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Medulloblastoma 1Kidney Neoplasms 1Hemangiopericytoma, Malignant 1Glioma, Subependymal 1Glioma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Dermatofibrosarcoma 1

Interventions

Temozolomide 4Irinotecan 3abemaciclib 2Radiotherapy 2Cyclophosphamide 2Bevacizumab 2palbociclib 1dostarlimab 1dinutuximab 1adavosertib 1Vorinostat 1Vincristine 1Valproic Acid 1Topotecan 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Mebendazole 1Granulocyte-Macrophage Colony-Stimulating Factor 1Etoposide 1Eflornithine 1Carboplatin 1CLR1404 11-methyltryptophan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diffuse Intrinsic Pontine Glioma × Radiotherapy, Conformal × Sarcoma × Clear all
NCT01189266 2021-10-28

Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

National Cancer Institute (NCI)

Phase 1/2 Completed
79 enrolled 17 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡